[go: up one dir, main page]

MX2010003250A - Composicion y metodo de ingrediente sensible estabilizado. - Google Patents

Composicion y metodo de ingrediente sensible estabilizado.

Info

Publication number
MX2010003250A
MX2010003250A MX2010003250A MX2010003250A MX2010003250A MX 2010003250 A MX2010003250 A MX 2010003250A MX 2010003250 A MX2010003250 A MX 2010003250A MX 2010003250 A MX2010003250 A MX 2010003250A MX 2010003250 A MX2010003250 A MX 2010003250A
Authority
MX
Mexico
Prior art keywords
composition
sensitive ingredient
ingredient
pregelatinized starch
stabilized
Prior art date
Application number
MX2010003250A
Other languages
English (en)
Other versions
MX339598B (es
Inventor
Paul Alfred Cimiluca
Sansoles Arnal
Jorge Zambrano
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2010003250A publication Critical patent/MX2010003250A/es
Publication of MX339598B publication Critical patent/MX339598B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2303/00—Characterised by the use of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08J2303/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invenci?n comprende un m?todo para lograr la estabilizaci?n de ingredientes en una composici?n; el m?todo comprende los pasos de: cambiar un almid?n pregelatinizado con al menos un ingrediente sensible; adsorber dicho ingrediente sensible en el almid?n pregelatinizado; y en donde dicho ingrediente sensible se distribuye uniformemente a trav?s de dicho almid?n pregelatinizado.
MX2010003250A 2007-09-24 2008-09-24 Composicion y metodo de ingrediente sensible estabilizado. MX339598B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99501907P 2007-09-24 2007-09-24
US4235008P 2008-04-04 2008-04-04
PCT/IB2008/053892 WO2009040750A1 (en) 2007-09-24 2008-09-24 Composition and method of stabilized sensitive ingredient

Publications (2)

Publication Number Publication Date
MX2010003250A true MX2010003250A (es) 2010-04-09
MX339598B MX339598B (es) 2016-06-01

Family

ID=40336439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003250A MX339598B (es) 2007-09-24 2008-09-24 Composicion y metodo de ingrediente sensible estabilizado.

Country Status (9)

Country Link
US (1) US9078824B2 (es)
EP (1) EP2200590A1 (es)
CN (1) CN101801349A (es)
AU (1) AU2008303230B2 (es)
BR (1) BRPI0817332A2 (es)
CA (1) CA2700983C (es)
MX (1) MX339598B (es)
RU (1) RU2466741C2 (es)
WO (1) WO2009040750A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
RU2605299C2 (ru) 2011-02-14 2016-12-20 Дзе Проктер Энд Гэмбл Компани Твердая единица дозирования в пленочной оболочке, содержащей мед
WO2014127118A1 (en) 2013-02-13 2014-08-21 The Procter & Gamble Company Anise flavored medication
CA2951739C (en) 2014-07-01 2023-09-19 Tntgamble, Inc. Bi-layer dual release probiotic tablets
WO2016057615A1 (en) * 2014-10-08 2016-04-14 Alva-Amco Pharmacal Companies, Inc. Composition for nap promotion
FR3047663A1 (fr) * 2016-02-12 2017-08-18 Idl Int Drug Licensing Comprime dispersible
CA3038263C (en) 2016-09-26 2022-04-05 The Procter & Gamble Company Extended relief dosage form
IT202200008018A1 (it) * 2022-04-22 2023-10-22 Calliero S P A Processo per la polverizzazione e stabilizzazione di oli essenziali comprendenti furanodieni
CN117017932B (zh) * 2023-08-24 2024-05-24 浙江和沐康医药科技有限公司 一种舒林酸片组合物及其制备方法和应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453368A (en) 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
US3480185A (en) 1966-06-20 1969-11-25 Johnson & Johnson Charged effervescing agent and medicament dispensing metering valve-actuated aerosol container producing a dose of medicament and carbonation in water
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
JP2948317B2 (ja) 1991-05-28 1999-09-13 マクニール―ピーピーシー・インコーポレーテツド 噛める薬物投与用組成物
US5409709A (en) 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5674522A (en) 1993-10-07 1997-10-07 Mcneil-Ppc, Inc. Beverage concentrate for drug delivery
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
JPH08325145A (ja) 1995-05-26 1996-12-10 Sumitomo Pharmaceut Co Ltd 安定なイソプロピルアンチピリン含有製剤
EP0935523B1 (en) 1996-10-28 2004-09-29 Inc. General Mills Embedding and encapsulation of controlled release particles
JP4384278B2 (ja) 1998-05-26 2009-12-16 東亜薬品株式会社 イブプロフェン含有粒剤
US6410052B1 (en) 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
ES2688273T3 (es) 1999-03-31 2018-10-31 Janssen Pharmaceutica Nv Almidón pregelatinizado en una formulación de liberación controlada
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US20010043959A1 (en) * 2000-02-23 2001-11-22 Daniel Gelber Composition and method for treating the effects of diseases and maladies
JP2001261580A (ja) 2000-03-14 2001-09-26 Taisho Pharmaceut Co Ltd 用時溶解型医薬
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
RU2286156C2 (ru) * 2001-10-15 2006-10-27 Ферринг Бв Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона
GB0206861D0 (en) * 2002-03-22 2002-05-01 Glaxo Group Ltd Medicaments
WO2003089007A1 (en) 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
MY136318A (en) 2002-07-25 2008-09-30 Pharmacia Corp Sustained-release tablet composition
JP4373649B2 (ja) 2002-08-01 2009-11-25 ロート製薬株式会社 経口用液剤
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20050232987A1 (en) 2004-03-12 2005-10-20 Viswanathan Srinivasan Dosage form containing a morphine derivative and another drug
DE10359790A1 (de) 2003-12-19 2005-07-21 Bayer Healthcare Ag Brausezubereitung einer basischen arzneilich wirksamen Substanz
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
BRPI0518553A2 (pt) * 2004-12-13 2008-11-25 Mcneil Ppc Inc composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada
BRPI0519212A2 (pt) 2004-12-23 2009-01-06 Mcneil Ppc Inc composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
CN1679525A (zh) * 2005-01-12 2005-10-12 复旦大学 复方对乙酰氨基酚口腔崩解片
US7851006B2 (en) * 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
EP1757274B1 (de) 2005-08-08 2012-07-25 Stada Arzneimittel Ag Brausezubereitung gegen Erkältungssymptome
CN1732938A (zh) * 2005-08-31 2006-02-15 上海医药(集团)有限公司 复方对乙酰氨基酚口腔崩解片
US20070141147A1 (en) 2005-12-21 2007-06-21 Auriga Laboratories, Inc. Sequential release pharmaceutical formulations
US20070160695A1 (en) 2006-01-09 2007-07-12 Clouatre Dallas L Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativum
EP2049087A2 (en) * 2006-07-21 2009-04-22 LAB International SRL Hydrophilic abuse deterrent delivery system
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine

Also Published As

Publication number Publication date
BRPI0817332A2 (pt) 2015-03-24
US9078824B2 (en) 2015-07-14
EP2200590A1 (en) 2010-06-30
AU2008303230B2 (en) 2014-07-03
RU2466741C2 (ru) 2012-11-20
MX339598B (es) 2016-06-01
CA2700983C (en) 2013-07-30
WO2009040750A1 (en) 2009-04-02
AU2008303230A1 (en) 2009-04-02
CN101801349A (zh) 2010-08-11
CA2700983A1 (en) 2009-04-02
RU2010106225A (ru) 2011-11-10
US20090082316A1 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
MX339598B (es) Composicion y metodo de ingrediente sensible estabilizado.
WO2008085570A3 (en) Flux formulations
IL200684A0 (en) Heterocyclic cyclopamine analog compounds, compositions comprising the same and uses thereof
EP2497470B8 (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
IL250858B (en) A tetracycline compound, a pharmaceutical composition comprising the tetracycline compound, and the tetracycline compound or the pharmaceutical composition for treating a tetracycline responsive state
WO2010075836A3 (de) Heterocyclische verbindungen und deren verwendung in elektronischen und optoelektronischen bauelementen
MY154909A (en) Novel thiophene derivatives
CL2012000887A1 (es) Mezcla fungicida sinergica que comprende fluorocitosina y otros compuestos fungicos; composicion fungicida que comprende dicha mezcla y un adyuvante agricolamente aceptable o portador.
IL214472A0 (en) Jun n-terminal kinase inhibitor compounds, compositions comprising the same and uses thereof
TW200717389A (en) Luminance adjustment
WO2010054056A3 (en) Nilotinib hci crystalline forms
IL205705A (en) Anti-flu antibodies, preparations containing them and their uses
PL2018184T3 (pl) Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
EP2028222A4 (en) ORIENTED POLYMER FILM OF NORBORNENE COMPOUND ADDITION ONLY, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF
SI2057153T1 (sl) (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
PL2252669T3 (pl) Kompozycja typu azeotropu 1,1,1-trifluoro-3-chloropropenu (HCFO-1233zd) i octanu metylu
ZA200900304B (en) Antifungal compositions containing the endophyte fungus alternaria alternata and,or its metabolites,as antagonist agents of plasmopara viticola
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
GB2450007A (en) Dynamic update adaptive idle timer
EP2058372A4 (en) DEHYDRATING COMPOSITION, MOLDED DEHYDRATING, METHOD FOR CONTROLLING BALANCE HUMIDITY FOR SUCH A COMPOSITION, AND METHOD FOR CONTROLLING BALANCE MOISTURE RETENTION TIME
TW200940847A (en) Damper and fastening device using the same
WO2005070398A8 (en) Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents
EP1848428A4 (en) THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGS
EP1970194A4 (en) MOISTURE-RESISTANT CELLULOSE SAMPLE FILM, POLARISATOR PROTECTION FILM AND POLARIZER
MY152388A (en) Composition and method for controlling plant diseases

Legal Events

Date Code Title Description
FG Grant or registration